Crizotinib
Inhibitors
| Trivial name | NULL |
| Catalog Number | CS-O-01256 |
| Alternative Name(s) | 3-[(1R)-1-(2,61-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine; (R)-3-[1-(2,6henyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylamine; PF 02341066; PF 2341066; [3-[[(R)-1-(2,6-Dchloro-3- |
| Research Area | Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent. |
| Molecular Formula | NULL |
| CAS# | 877399-52-5 |
| Purity | >98% |
| Inchi | NULL |
| Inchi Key | NULL |
| SMILES | C[C@H](C(C(Cl)=CC=C1F)=C1Cl)OC2=CC(C3=CN(C4CCNCC4)N=C3)=CN=C2N |
| Beilstein Registry Number | NULL |
| Condensed Formula | NULL |
| EC Number | NULL |
| PubChem Chemical Structure ID | NULL |
| Size | 500 g |
| Supplier Page | https://www.clearsynth.com/en/CSO01256.html |
| Additional Information | NULL |